| Defining left bundle branch block in the era of cardiac resynchronization therapy DG Strauss, RH Selvester, GS Wagner The American journal of cardiology 107 (6), 927-934, 2011 | 716 | 2011 |
| The comprehensive in vitro proarrhythmia assay (CiPA) initiative—update on progress T Colatsky, B Fermini, G Gintant, JB Pierson, P Sager, Y Sekino, ... Journal of pharmacological and toxicological methods 81, 15-20, 2016 | 384 | 2016 |
| A new perspective in the field of cardiac safety testing through the comprehensive in vitro proarrhythmia assay paradigm B Fermini, JC Hancox, N Abi-Gerges, M Bridgland-Taylor, KW Chaudhary, ... Journal of biomolecular screening 21 (1), 1-11, 2016 | 296 | 2016 |
| Effect of sunscreen application under maximal use conditions on plasma concentration of sunscreen active ingredients: a randomized clinical trial MK Matta, R Zusterzeel, NR Pilli, V Patel, DA Volpe, J Florian, L Oh, ... Jama 321 (21), 2082-2091, 2019 | 294 | 2019 |
| International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment K Blinova, Q Dang, D Millard, G Smith, J Pierson, L Guo, M Brock, HR Lu, ... Cell reports 24 (13), 3582-3592, 2018 | 289 | 2018 |
| An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel WJ Crumb Jr, J Vicente, L Johannesen, DG Strauss Journal of pharmacological and toxicological methods 81, 251-262, 2016 | 259 | 2016 |
| Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias K Blinova, J Stohlman, J Vicente, D Chan, L Johannesen, ... Toxicological Sciences 155 (1), 234-247, 2017 | 245 | 2017 |
| Differentiating drug‐induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil L Johannesen, J Vicente, JW Mason, C Sanabria, K Waite‐Labott, ... Clinical Pharmacology & Therapeutics 96 (5), 549-558, 2014 | 236 | 2014 |
| Effect of sunscreen application on plasma concentration of sunscreen active ingredients: a randomized clinical trial MK Matta, J Florian, R Zusterzeel, NR Pilli, V Patel, DA Volpe, Y Yang, ... Jama 323 (3), 256-267, 2020 | 216 | 2020 |
| Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data R Zusterzeel, KA Selzman, WE Sanders, DA Caños, KM O’Callaghan, ... JAMA internal medicine 174 (8), 1340-1348, 2014 | 210 | 2014 |
| The QRS complex—a biomarker that “images” the heart: QRS scores to quantify myocardial scar in the presence of normal and abnormal ventricular conduction DG Strauss, RH Selvester Journal of electrocardiology 42 (1), 85-96, 2009 | 191 | 2009 |
| ECG Quantification of Myocardial Scar in Cardiomyopathy Patients With or Without Conduction Defects DG Strauss, RH Selvester, JAC Lima, H Arheden, JM Miller, ... Circulation: Arrhythmia and Electrophysiology 1 (5), 327-336, 2008 | 180 | 2008 |
| Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment S Dutta, KC Chang, KA Beattie, J Sheng, PN Tran, WW Wu, M Wu, ... Frontiers in Physiology 8, 616, 2017 | 168 | 2017 |
| Improving the in silico assessment of proarrhythmia risk by combining hERG (human ether-à-go-go-related gene) channel–drug binding kinetics and multichannel pharmacology Z Li, S Dutta, J Sheng, PN Tran, W Wu, K Chang, T Mdluli, DG Strauss, ... Circulation: Arrhythmia and Electrophysiology 10 (2), e004628, 2017 | 160 | 2017 |
| Effectiveness of prehospital wireless transmission of electrocardiograms to a cardiologist via hand-held device for patients with acute myocardial infarction (from the Timely … GL Adams, PT Campbell, JM Adams, DG Strauss, K Wall, J Patterson, ... The American journal of cardiology 98 (9), 1160-1164, 2006 | 160 | 2006 |
| Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative Z Li, BJ Ridder, X Han, WW Wu, J Sheng, PN Tran, M Wu, A Randolph, ... Clinical Pharmacology & Therapeutics 105 (2), 466-475, 2019 | 135 | 2019 |
| Late sodium current block for drug‐induced long QT syndrome: results from a prospective clinical trial L Johannesen, J Vicente, JW Mason, C Erato, C Sanabria, K Waite‐Labott, ... Clinical Pharmacology & Therapeutics 99 (2), 214-223, 2016 | 135 | 2016 |
| Comprehensive T wave morphology assessment in a randomized clinical study of dofetilide, quinidine, ranolazine, and verapamil J Vicente, L Johannesen, JW Mason, WJ Crumb, E Pueyo, N Stockbridge, ... Journal of the American Heart Association 4 (4), e001615, 2015 | 135 | 2015 |
| Mechanistic model‐informed proarrhythmic risk assessment of drugs: review of the “CiPA” initiative and design of a prospective clinical validation study J Vicente, R Zusterzeel, L Johannesen, J Mason, P Sager, V Patel, ... Clinical Pharmacology & Therapeutics 103 (1), 54-66, 2018 | 118 | 2018 |
| Common genetic variant risk score is associated with drug-induced QT prolongation and torsade de pointes risk: a pilot study DG Strauss, J Vicente, L Johannesen, K Blinova, JW Mason, P Weeke, ... Circulation 135 (14), 1300-1310, 2017 | 117 | 2017 |
Jose VicenteCenter for Drug Evaluation and Research, U.S. Food and Drug Administration確認したメール アドレス: fda.hhs.gov
